MSCs isolated from patients with ischemic vascular disease have normal angiogenic potential.
作者信息
Sanz-Nogués Clara, O'Brien Timothy
机构信息
Regenerative Medicine Institute, National University of Ireland, Galway, Ireland.
出版信息
Mol Ther. 2014 Nov;22(11):1888-9. doi: 10.1038/mt.2014.191.
Abstract
摘要
相似文献
1
MSCs isolated from patients with ischemic vascular disease have normal angiogenic potential.
Mol Ther. 2014 Nov;22(11):1888-9. doi: 10.1038/mt.2014.191.
2
Angiogenic properties of mesenchymal stem cells in a mouse model of limb ischemia.
Methods Mol Biol. 2014;1213:147-69. doi: 10.1007/978-1-4939-1453-1_13.
3
Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls.
Mol Ther. 2014 Nov;22(11):1960-70. doi: 10.1038/mt.2014.161. Epub 2014 Sep 1.
4
Netrin-1 with stem cells promote angiogenesis in limb ischemic rats.
J Surg Res. 2014 Dec;192(2):664-9. doi: 10.1016/j.jss.2014.07.006. Epub 2014 Jul 5.
5
VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity.
Stem Cell Res Ther. 2016 Apr 4;7:49. doi: 10.1186/s13287-016-0297-0.
6
Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice.
Cytotherapy. 2016 Feb;18(2):219-28. doi: 10.1016/j.jcyt.2015.10.013. Epub 2015 Dec 28.
7
Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats.
Cell Transplant. 2017 Jan 24;26(1):45-61. doi: 10.3727/096368916X692726. Epub 2016 Aug 5.
8
Overexpression of Gremlin1 in Mesenchymal Stem Cells Improves Hindlimb Ischemia in Mice by Enhancing Cell Survival.
J Cell Physiol. 2017 May;232(5):996-1007. doi: 10.1002/jcp.25578. Epub 2016 Dec 20.
9
Protein profiling and angiogenic effect of hypoxia-cultured human umbilical cord blood-derived mesenchymal stem cells in hindlimb ischemia.
Tissue Cell. 2017 Dec;49(6):680-690. doi: 10.1016/j.tice.2017.09.006. Epub 2017 Sep 20.
10
Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization.
Stem Cells Dev. 2010 Oct;19(10):1511-22. doi: 10.1089/scd.2009.0321.
引用本文的文献
1
Insights into Inflammatory Priming of Adipose-Derived Mesenchymal Stem Cells: Validation of Extracellular Vesicles-Embedded miRNA Reference Genes as A Crucial Step for Donor Selection.
Cells. 2019 Apr 23;8(4):369. doi: 10.3390/cells8040369.
2
Donor variability among anti-inflammatory pre-activated mesenchymal stromal cells.
Technology (Singap World Sci). 2016 Sep;4(3):201-215. doi: 10.1142/S2339547816500084.
3
Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies.
Stem Cell Res Ther. 2016 Sep 9;7(1):131. doi: 10.1186/s13287-016-0394-0.
本文引用的文献
1
Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls.
Mol Ther. 2014 Nov;22(11):1960-70. doi: 10.1038/mt.2014.161. Epub 2014 Sep 1.
2
Autologous bone marrow cell therapy for peripheral arterial disease.
Stem Cells Cloning. 2012 Sep 6;5:5-14. doi: 10.2147/SCCAA.S28121.
3
A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.
J Transl Med. 2013 Jun 10;11:143. doi: 10.1186/1479-5876-11-143.
4
Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients.
PLoS One. 2013;8(1):e55592. doi: 10.1371/journal.pone.0055592. Epub 2013 Jan 31.
5
Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?
Immunol Cell Biol. 2013 Jan;91(1):40-51. doi: 10.1038/icb.2012.67. Epub 2012 Dec 4.
6
Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia.
Stem Cell Res Ther. 2012 Jul 30;3(4):28. doi: 10.1186/scrt119.
7
Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study.
Circ J. 2012;76(7):1750-60. doi: 10.1253/circj.cj-11-1135. Epub 2012 Apr 12.
8
Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial.
Diabetes Res Clin Pract. 2011 Apr;92(1):26-36. doi: 10.1016/j.diabres.2010.12.010. Epub 2011 Jan 8.
9
Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair.
Circulation. 2010 Dec 7;122(23):2419-29. doi: 10.1161/CIRCULATIONAHA.110.955971. Epub 2010 Nov 22.
10
Immunological aspects of allogeneic mesenchymal stem cell therapies.
Hum Gene Ther. 2010 Dec;21(12):1641-55. doi: 10.1089/hum.2010.156.
Zotero 插件